7T扩散加权成像预测垂体大腺瘤质地的分析
本研究纳入13例垂体大腺瘤患者,术前行7T MRI扩散加权成像,将肿瘤表观扩散系数(ADC)与邻近颞叶灰质ADC归一化,并与术中质地评分、组织病理学和切除程度进行相关性分析。结果显示校正ADC值与肿瘤质地(r=-0.60,p=0.029)及三色染色程度(r=-0.72,p=0.009)显著相关,预测术中质地评分的最佳ADC比值为0.87(灵敏度80%,特异度100%,AUC 0.90;p=0.043)。作者认为高分辨率ADC是肿瘤质地的敏感测量指标,7T DWI可能具有临床价值。
要点
- 校正ADC值与肿瘤质地呈显著负相关(r=-0.60,p=0.029),ADC值越高肿瘤越软。
- 预测术中质地评分的最佳ADC比值为0.87,灵敏度80%、特异度100%、AUC 0.90(p=0.043)。
- 全切除肿瘤的校正ADC值(1.54)高于次全切除肿瘤(0.85)(p=0.02)。
核心结论
- 作者认为垂体腺瘤的高分辨率ADC是肿瘤质地的敏感测量指标,7T DWI可能在垂体大腺瘤患者的术前评估和外科管理中具有临床价值。
研究设计与样本
- 本研究纳入13例垂体大腺瘤患者,术前行7T MRI包括DWI采集,肿瘤ADC归一化至邻近颞叶灰质ADC。
- 所有患者均接受切除术,由一名对ADC值不知情的神经外科医生使用客观标准从1(最软)到5(最硬)评定肿瘤硬度。
- 肿瘤标本由一名对ADC值不知情的神经病理学家进行组织病理学评估细胞密度、胶原含量和血管分布。
- 将肿瘤ADC与术中质地评分、组织病理学和切除程度进行相关性分析,并进行受试者工作特征(ROC)曲线分析以确定预测肿瘤质地的阈值。
主要发现
- 校正ADC值与肿瘤硬度(r=-0.60,p=0.029)和三色染色程度(r=-0.72,p=0.009)均显著相关,ADC值越大与肿瘤硬度降低和胶原染色减少相关。
- ADC值与肿瘤血管分布的相关性不显著(r=-0.09,p=0.78)。
- 全切除肿瘤的校正ADC值(1.54)高于次全切除肿瘤(0.85)(p=0.02);中等肿瘤细胞密度者的ADC值(1.51)高于高肿瘤细胞密度者(0.8)(p=0.035)。
- 部分切除肿瘤表现出更高硬度评分的关联为趋势水平(3 vs 1.7;p=0.051)。
- 三色染色程度与肿瘤硬度呈正相关(r=0.60,p=0.04)。
关键数值与推荐
- 预测术中质地评分的最佳阈值为ADC比值0.87(灵敏度80%,特异度100%,AUC 0.90;p=0.043)。
- 区分切除程度的最佳截断值为1.19(灵敏度85.7%,特异度83.3%,AUC 0.833;p=0.046)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endoscopic surgery is an effective treatment strategy for pituitary adenomas; however, intrinsic tumor properties such as tumor consistency can challenge or preclude gross-total resection. Preoperative characterization of tumor consistency may help to guide the surgical approach and to predict the extent of resection that is possible. Advanced radiological modalities such as 7T diffusion-weighted imaging (DWI) may be useful in probing biological tissue properties of pituitary adenomas. The objective of the present study was to examine 7T DWI as a novel method of measuring the consistency of pituitary adenomas. METHODS: Thirteen patients with pituitary macroadenomas underwent 7T MRI, including a DWI image acquisition. Tumor apparent diffusion coefficient (ADC) was normalized to the adjacent temporal gray matter ADC. All patients underwent resection, and a single neurosurgeon blinded to ADC values rated tumor firmness from 1 (least firm) to 5 (most firm) using objective criteria. The tumor specimens were evaluated histopathologically for cellularity, collagen content, and vascularity by a neuropathologist who was also blinded to ADC values. The tumor ADC was correlated with intraoperative consistency rating, histopathology, and extent of resection. Receiver operating characteristic (ROC) curve analyses were performed to identify thresholds to predict tumor consistency. RESULTS: Corrected ADC values were significantly correlated with both tumor firmness (r = -0.60, p = 0.029) and the extent of trichrome staining (r = -0.72, p = 0.009) such that greater ADC values were associated with both decreased tumor firmness and decreased collagen staining. Correlations between ADC values and tumor vascularity were not significant (r = -0.09, p = 0.78). Corrected ADC values in totally resected tumors (1.54) were greater than those in subtotally resected tumors (0.85) (p = 0.02), and ADC values were greater with moderate tumor cellularity (1.51) than with high tumor cellularity (0.8) (p = 0.035). There was a trend-level association for partial resections to exhibit greater tumor firmness rating (3 vs 1.7; p = 0.051). Finally, the degree of trichrome staining positively correlated with tumor firmness (r = 0.60, p = 0.04). The optimal threshold for predicting intraoperative consistency rating was an ADC ratio of 0.87 (sensitivity 80%, specificity 100%, area under the curve [AUC] 0.90; p = 0.043). The optimal cutoff for distinguishing the extent of resection was 1.19 (sensitivity 85.7%, specificity 83.3% AUC 0.833; p = 0.046). CONCLUSIONS: The authors' results suggest that a high-resolution ADC of pituitary adenomas is a sensitive measure of tumor consistency. 7T DWI may hold clinical value in the preoperative workup and surgical management of patients with pituitary macroadenomas.
引用
- Rutland JW, Loewenstern J, Ranti D, et al. Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency. J Neurosurg. 2020. PMID: 32109870. doi:10.3171/2019.12.JNS192940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。